Global Heparin Market – Overview
Heparin more precisely called unfractionated heparin, is a naturally occurring glycosaminoglycan and also an anticoagulant that is used for the prevention as well as treatment of thrombotic events like deep vein thrombosis (DVT) and pulmonary embolism (PE). Heparin is also used during cardiac surgery to prevent excess coagulation. Heparin also plays an important role in renal replacement therapy thus preventing coagulation. Heparin is also used for treatment in other thrombotic states like atrial fibrillation undergoing cardioversion, systemic emboli, etc. The dose of heparin differs depending on the indication. In obese patients, maximum bolus infusion and continuous infusion rate are maintained.
Heparin when administered in the circulation, binds with various proteins, mainly antithrombin. Antithrombin is a glycoprotein that inactivates several enzymes that are involved in the clotting mechanism of the human body. Thus, binding with antithrombin leads to blockage of several different clotting factors, two of which are the prominent ones, Factor IIa and Factor Xa. Thus, due to the blockage of these factors, fibrinogen is unable to convert into fibrin. Thus, the process of blood clotting is prolonged. Heparin here does not completely stop the clotting of blood or affect the bleeding time, it simply prolongs the clotting time of the blood. Heparin could be administered by intravenous (IV) route as well as subcutaneous (SQ) route.
Global Heparin Market – Competitive Insight
In April 2020, Hepalink bought SPL for USD 337 million for the supply of heparin product raw materials.
Some of the Global Heparin Market Include –
Global Heparin Market – Growth Drivers
There has been a constant increase in the events of chronic diseases like coronary artery disease and chronic kidney disease. According to The Global Burden of Diseases, Injury, and Risk Factors study in 2019 8.9 million women and 9.6 million men died due to cardiovascular diseases, and of which more than 6 million were between the ages of 30-70. This data indicates that it is likely that the cases of cardiovascular diseases will increase as a result of population growth and aging. Thus the above factors will help in the growth of the global heparin market. It has also been observed that there is an increase in the geriatric population i.e. the elderly population. A report from WHO states that by 2030, 1 in every 6 people in the world will be aged 60 or above. WHO also estimates that the geriatric population will increase from 1 billion in 2020 to 1.4 billion in 2050. This data clearly explains why chronic diseases will increase in the future, thus being the growth driver for the global heparin market. Moreover, the funding of the government in an increase of health services also is a growth driver for the heparin market.
Global Heparin Market – Restraints
Despite the anticoagulant activity of heparin, there are many side effects of heparin. According to an article published by NIH, bleeding is the major complication of heparin. Hemorrhagic complications due to heparin may be fatal and life-threatening. Accidental bleeding may occur at surgical sites or open wounds. These factors cause the depletion in the use of heparin. Moreover, thrombocytopenia occurs in up to 30% of the patients who receive heparin during their treatment. Heparin-induced thrombocytopenia (HIT) is more serious in the case of heparin administration thus being another restrain for the particular market. Various substitutes for heparin are induced in the market. According to an article in Oxford Academic, Argatoban as a substitute for heparin in cardiopulmonary bypass surgery is discussed. Thus, the substitutes of heparin as an anticoagulant is another point that may restrain the global heparin market.
Global Heparin Market – Opportunities
According to the WHO estimate the geriatric population will increase from 1 billion in 2020 to 1.4 billion in 2050. Thus, increase in the geriatric population also in turn means an increase in cardiovascular complications. Therefore, use of heparin in the treatment of complications also increases. Thus there a constant growth opportunities in the heparin market. Moreover, the inclusion of low molecular weight heparin (LMWH) also provides future opportunities in the particular market. Rise in health awareness and expenditure are expected to propel the heparin market. In the Covid-19 period, heparin was primarily used as an anticoagulant along with other therapies. The use of heparin has increased since the Covid-19 period. Thus, there stands an opportunity for the heparin market as heparin is primarily used as an agent to prevent coagulopathy.
Global Heparin Market – Geographical Insight
The market for dry eye disease is segmented into regions such as North America, Latin America, Europe, Asia-Pacific, the Middle East & Africa. North America is the largest market for heparin due to well-established healthcare infrastructure facilities and widespread diagnosis and treatment. Europe is expected to be the other prominent heparin market. Growth in the infrastructure in the health industry is the primary reason. Asia Pacific is another prominent market. The reason is an increase in the number of the elderly population which in turn leads to an increase in the opportunities for the global heparin market.
Global Heparin Market – Key Development
Research Methodology: Aspects
Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.
The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.
Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.
Key phases involved in in our research process are mentioned below:
Understanding Clients’ Objectives:
Extensive Discussions and Consultations:
Industry and Market Segment Analysis:
Target Audience Understanding:
Identifying Challenges and Opportunities:
Grasping Specific Goals:
Data Collection:
Primary Research Process:
Secondary Research Process:
Data Analysis:
The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.
Transformation of Raw Data:
Utilization of Analytical Methods:
Statistical Analysis:
Qualitative Analysis Techniques:
Integrity and Validity Maintenance:
Data Validation:
The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.
Importance of Data Validation:
Scrutiny of Collected Data:
Validation Techniques:
Internal Quality Assurance Protocols:
We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Cognizance market research is continuously guiding customers around the globe towards strategies for transformational growth. Today, businesses have to innovate more than ever before, not just to survive, but to succeed in the future
© 2023 All rights Reserved. Cognizance Market Research